Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | VRTX | REGN | ||
| Company | Gsk Plc ADR | Vertex Pharmaceutic | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 51.79 | 447.02 | 728.51 | ||
| High | 53.10 | 452.08 | 743.16 | ||
| Low | 51.71 | 441.20 | 727.96 | ||
| Latest | 52.95 | 448.62 | 741.69 | ||
| Change | +0.96 | -2.61 | +5.16 | ||
| % Change | +1.85% | -0.58% | +0.70% | ||
| Volume | 4,778,600 | 1,224,200 | 507,900 | ||
| 20-Day Average Volume | 4,873,865 | 1,444,415 | 636,165 | ||
| Previous Close | 51.99 | 451.23 | 736.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.04 | 470.38 | 761.79 | ||
| 20-Day Raw Stochastic | 16.75% | 11.12% | 20.65% | ||
| 20-Day Relative Strength | 44.37 | 43.92 | 45.35 | ||
| Weighted Alpha | +38.58 | -4.57 | +22.54 | ||
| Today's Opinion | 56% Buy | 40% Buy | 24% Buy | ||
| Previous Opinion | 56% Buy | 48% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.86% since 03/17/26 | -3.00% since 03/17/26 | -2.29% since 03/17/26 | ||
| Low | 51.54 on 03/20/26 | 441.20 on 03/24/26 | 727.88 on 03/19/26 | ||
| High | 53.10 on 03/24/26 | 463.96 on 03/18/26 | 757.59 on 03/18/26 | ||
| 1-Month | |||||
| %Chg | -10.44% since 02/24/26 | -7.96% since 02/24/26 | -3.95% since 02/24/26 | ||
| Low | 51.54 on 03/20/26 | 441.20 on 03/24/26 | 727.88 on 03/19/26 | ||
| High | 59.94 on 02/25/26 | 507.92 on 03/10/26 | 794.77 on 03/03/26 | ||
| 3-Month | |||||
| %Chg | +8.15% since 12/24/25 | -3.10% since 12/24/25 | -5.36% since 12/24/25 | ||
| Low | 47.62 on 01/20/26 | 429.00 on 01/20/26 | 718.38 on 01/20/26 | ||
| High | 61.69 on 02/18/26 | 507.92 on 03/10/26 | 821.11 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +31.78% since 09/24/25 | +19.12% since 09/24/25 | +28.55% since 09/24/25 | ||
| Low | 39.29 on 09/25/25 | 377.02 on 09/25/25 | 541.00 on 10/13/25 | ||
| High | 61.69 on 02/18/26 | 507.92 on 03/10/26 | 821.11 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 105,866,088 | 114,629,032 | 77,865,952 | ||
| Shares Outstanding, K | 2,036,278 | 254,034 | 105,720 | ||
| Annual Sales | 43,077,970,000 | 12,001,300,000 | 14,342,900,000 | ||
| Annual Net Income | 7,537,690,000 | 3,953,200,000 | 4,504,900,000 | ||
| Last Quarter Sales | 11,424,970,000 | 3,190,000,000 | 3,884,300,000 | ||
| Last Quarter Net Income | 851,670,000 | 1,191,100,000 | 844,600,000 | ||
| 60-Month Beta | 0.44 | 0.31 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.68 on 02/04/26 | 5.03 on 02/12/26 | 11.44 on 01/30/26 | ||
| Latest Earnings Date | 04/29/26 | 05/04/26 | 05/05/26 | ||
| Most Recent Dividend | 0.478 on 02/20/26 | N/A | 0.940 on 02/20/26 | ||
| Next Ex-Dividends Date | 02/20/26 | N/A | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 11.47 | 27.65 | 20.31 | ||